• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Catalog Number ADM07004008P
Device Problem Burst Container or Vessel (1074)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/03/2020
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician used an inpact admiral during patient treatment.An inflation device was used with saline and contrast for balloon inflation.No damage noted to packaging prior to use nor issues noted when removing the device from the packaging.Ifu was followed and the device was prepped without issue.No resistance was noted during advancement of the device.It is reported a balloon burst occurred during last balloon inflation at 14atm.2 prior inflations had been applied to the device.No balloon fragments were left in the patient.No injury reported.
 
Manufacturer Narrative
Product analysis: the inpact admiral device was returned to medtronic investigation lab for evaluation.The device was returned with blood and residue visible within the balloon and catheter.A 0.035 inch guide wire was loaded through the inner lumen with no resistance noted.Negative prep did not detect the evidence of a leak on the device.Upon pressurization of the device a pin-hole leak was observed on the mid balloon material.There were multiple scratches and damage evident to the balloon material surrounding the site of the pin-hole tear.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: the in.Pact admiral was using during the treatment of a calcified lesion in the patient's superficial femoral artery (sfa).The type of balloon burst is unknown.The balloon did not fragment.There were no difficulties experienced when removing the device from the patient.No extra steps were required to complete the procedure.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9785649
MDR Text Key190331508
Report Number9612164-2020-01005
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P140010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 05/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/05/2020
Device Catalogue NumberADM07004008P
Device Lot Number0009529438
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/04/2020
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/03/2020
Initial Date FDA Received03/04/2020
Supplement Dates Manufacturer Received03/05/2020
03/09/2020
05/18/2020
Supplement Dates FDA Received03/09/2020
03/12/2020
05/20/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/06/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-